Rating History for IO Biotech (IOBT) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/8/2026 | Michael E Ulz | Downgrade | Underweight (Equalweight) |
0.36 (0.39) |
0.64 (0.30) |
-53.13% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/8/2026 | Michael E Ulz | Downgrade | Underweight (Equalweight) |
0.36 (0.39) |
0.64 (0.30) |
-53.13% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||